title: Evaluating the impact of pain management (PM) education on physician practice patterns--a continuing medical education (CME) outcomes study.
abstract: California Assembly Bill AB487 mandates that all practicing physicians are required to obtain 12 h of Continuing Medical Education in Pain Management and End of Life Care before the year 2006 in order to renew their state license to practice medicine. In order to determine the effectiveness of this bill in influencing the practice of medicine, we conducted the first of five planned annual Pain Management seminars and utilized physician questionnaires to determine possible practice changes as a result of this seminar. Eighty-one physicians representing 17 multiple specialties of medicine enrolled in this seminar. The topics included: management of malignant and non-malignant pain, pharmacology and management of side effects of opiate and non-opiate analgesics, and adjunctive therapies including depression management and spirituality issues. Physicians were asked to respond to an immediate post-seminar questionnaire and were subsequently queried 4 months following the conference. Fifty-one out of 81 physician registrants responded to an immediate post-attendance questionnaire, and 31 responded to the 4-month follow-up questionnaire. Responses included: [Please see text]. This audience represents the most motivated group of practitioners electing to receive Pain Management Education long before the mandated deadline. Sixty-seven percent expressed an interest in changing their practice following this intensive educational experience. Ninety percent responding to the follow-up evaluation indicated that their practices had changed, suggesting that this seminar series is effective in altering physician practice patterns (supported by Cancer Center Support Grant CA 33572 and Sarnat Foundation).
authors.affiliation: Department of Continuing Medical Education, City of Hope Comprehensive Cancer Center, 1500 E. Duarte Rd, Duarte, CA 91010, USA. lleong@coh.org
authors.forename: L
authors.initials: L
authors.lastname: Leong
authors.forename: J
authors.initials: J
authors.lastname: Ninnis
authors.forename: N
authors.initials: N
authors.lastname: Slatkin
authors.forename: M
authors.initials: M
authors.lastname: Rhiner
authors.forename: L
authors.initials: L
authors.lastname: Schroeder
authors.forename: B
authors.initials: B
authors.lastname: Pritt
authors.forename: J
authors.initials: J
authors.lastname: Kagan
authors.forename: T
authors.initials: T
authors.lastname: Ball
authors.forename: R
authors.initials: R
authors.lastname: Morgan
mesh_terms: D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002140:California; D004502:Education, Medical, Continuing; D005500:Follow-Up Studies; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D010818:Practice Patterns, Physicians'
chemical_list: D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid